CVS Group Plc 42.9% potential upside indicated by RBC Capital Markets

CVS Group Plc with ticker (LON:CVSG) now has a potential upside of 42.9% according to RBC Capital Markets.



RBC Capital Markets set a target price of 3,000 GBX for the company, which when compared to the CVS Group Plc share price of 1,714 GBX at opening today (30/03/2022) indicates a potential upside of 42.9%. Trading has ranged between 1,512 (52 week low) and 2,835 (52 week high) with an average of 456,259 shares exchanging hands daily. The market capitalisation at the time of writing is £1,244,512,000.

CVS Group plc (CVS) is a veterinary services provider. The Company operates in the four business segments, namely Veterinary Practices, Laboratories, Crematoria and Online Retail Business. It offers an integrated model with approximately 500 veterinary practices across its three territories, including eight specialist referral hospitals and 34 out-of-hours sites. Veterinary Practices provide specialist treatment for companion, equine and farm animals. The Company laboratories provide diagnostic services to CVS veterinary practices and third parties. It offers a range of tests with the ability to tailor specific profiles to its customers’ needs. Its crematoria provide pet cremation and clinical waste services to CVS practices and third-party practices, and cremations to animal owners. CVS online retail business, Animed Direct, sells prescription and nonprescription medicines, pet foods and a range of pet care products.